1. Home
  2. APLS vs DV Comparison

APLS vs DV Comparison

Compare APLS & DV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • DV
  • Stock Information
  • Founded
  • APLS 2009
  • DV 2008
  • Country
  • APLS United States
  • DV United States
  • Employees
  • APLS N/A
  • DV N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • DV Computer Software: Prepackaged Software
  • Sector
  • APLS Health Care
  • DV Technology
  • Exchange
  • APLS Nasdaq
  • DV Nasdaq
  • Market Cap
  • APLS 2.2B
  • DV 2.4B
  • IPO Year
  • APLS 2017
  • DV 2021
  • Fundamental
  • Price
  • APLS $17.69
  • DV $14.36
  • Analyst Decision
  • APLS Buy
  • DV Buy
  • Analyst Count
  • APLS 19
  • DV 18
  • Target Price
  • APLS $37.67
  • DV $18.92
  • AVG Volume (30 Days)
  • APLS 2.1M
  • DV 3.2M
  • Earning Date
  • APLS 07-31-2025
  • DV 07-29-2025
  • Dividend Yield
  • APLS N/A
  • DV N/A
  • EPS Growth
  • APLS N/A
  • DV N/A
  • EPS
  • APLS N/A
  • DV 0.29
  • Revenue
  • APLS $775,839,000.00
  • DV $681,128,000.00
  • Revenue This Year
  • APLS $1.01
  • DV $13.75
  • Revenue Next Year
  • APLS $22.14
  • DV $11.71
  • P/E Ratio
  • APLS N/A
  • DV $48.89
  • Revenue Growth
  • APLS 48.04
  • DV 15.30
  • 52 Week Low
  • APLS $16.10
  • DV $11.52
  • 52 Week High
  • APLS $42.47
  • DV $23.11
  • Technical
  • Relative Strength Index (RSI)
  • APLS 42.98
  • DV 51.55
  • Support Level
  • APLS $18.26
  • DV $14.10
  • Resistance Level
  • APLS $19.96
  • DV $16.59
  • Average True Range (ATR)
  • APLS 0.84
  • DV 0.59
  • MACD
  • APLS -0.08
  • DV -0.04
  • Stochastic Oscillator
  • APLS 19.22
  • DV 30.16

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About DV DoubleVerify Holdings Inc.

DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. Its solutions provide advertisers with unbiased data analytics that enable them to increase the effectiveness, quality, and return on their digital advertising investments. Its DV Authentic Ad, a proprietary metric of digital media quality, measures whether a digital ad was delivered in a brand-suitable environment, fully viewable, by a real person, and in the intended geography. The company's software interface, DV Pinnacle, delivers these metrics to customers in real time, allowing them to access critical performance data on their digital transactions. Geographically, the company operates in the United States and also has a presence in Germany, Singapore, France, Canada, Japan, and other countries.

Share on Social Networks: